MIST · Company research
Milestone Pharmaceuticals Inc. (MIST): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Milky Mist stock down 4.5% despite clarification on FSSAI action against its paneer products: How to trade... - Moneycontrol.com | Milky Mist stock down 4.5% despite clarification on FSSAI action against its paneer products: How to trade... Moneycontrol.com | View source ↗ | Moneycontrol.com | Oct 12, 2026 | neutral | 0 | 0.6 |
| Milky Mist stock down 5% despite clarification on FSSAI action against firm - Business Standard | Milky Mist stock down 5% despite clarification on FSSAI action against firm Business Standard | View source ↗ | Business Standard | Oct 12, 2026 | neutral | 0 | 0.6 |
| A trial of a nasal spray for fast, irregular heartbeats enrolls its first European patient. - Stock Titan | A trial of a nasal spray for fast, irregular heartbeats enrolls its first European patient. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| 78% of Gen Z says stress affects their skin. e.l.f. offers a $12 soothing mist. - Stock Titan | 78% of Gen Z says stress affects their skin. e.l.f. offers a $12 soothing mist. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Is Pantene Cream To Mist Launch Require Action From P&G Stock Investors? - Simply Wall Street | Is Pantene Cream To Mist Launch Require Action From P&G Stock Investors? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 3, 2026 | neutral | 0 | 0.6 |
| A Canadian patient joins a trial of a self-administered nasal spray for sudden fast heartbeats. - Stock Titan | A Canadian patient joins a trial of a self-administered nasal spray for sudden fast heartbeats. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| A heart-rhythm disorder interrupted daytime activity for 73% of patients between episodes - Stock Titan | A heart-rhythm disorder interrupted daytime activity for 73% of patients between episodes Stock Titan | View source ↗ | Stock Titan | Aug 27, 2026 | neutral | 0 | 0.6 |
| Milestone Pharmaceuticals stock gains on Phase 3 AFib trial - Investing.com | Milestone Pharmaceuticals stock gains on Phase 3 AFib trial Investing.com | View source ↗ | Investing.com | Aug 21, 2026 | neutral | 0 | 0.6 |
| Cantor Fitzgerald initiates Milestone Pharmaceuticals stock coverage with overweight rating - Investing.com | Cantor Fitzgerald initiates Milestone Pharmaceuticals stock coverage with overweight rating Investing.com | View source ↗ | Investing.com | Aug 20, 2026 | neutral | 0 | 0.6 |
| Milestone Pharmaceuticals: Reiterating Sell As The Losses Compound (NASDAQ:MIST) - Seeking Alpha | Milestone Pharmaceuticals: Reiterating Sell As The Losses Compound (NASDAQ:MIST) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 18, 2026 | neutral | 0 | 0.6 |
| MILESTONE PHARMACEUTICLS ($MIST) Releases Q2 2026 Earnings - Quiver Quantitative | MILESTONE PHARMACEUTICLS ($MIST) Releases Q2 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| Milestone Pharmaceuticals shares tumble after Q2 earnings miss - Yahoo Finance | Milestone Pharmaceuticals shares tumble after Q2 earnings miss Yahoo Finance | View source ↗ | Yahoo Finance | Aug 12, 2026 | neutral | 0 | 0.6 |
| What To Expect From Milestone Pharmaceuticals Inc (MIST) Q2 2026 Earnings - Yahoo Finance | What To Expect From Milestone Pharmaceuticals Inc (MIST) Q2 2026 Earnings Yahoo Finance | View source ↗ | Yahoo Finance | Aug 11, 2026 | neutral | 0 | 0.6 |
| India's Milky Mist cuts IPO size after Temasek deals, launch next week - Reuters | India's Milky Mist cuts IPO size after Temasek deals, launch next week Reuters | View source ↗ | Reuters | Aug 4, 2026 | neutral | 0 | 0.6 |
| After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST) - Yahoo Finance | After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST) Yahoo Finance | View source ↗ | Yahoo Finance | Jul 29, 2026 | neutral | 0 | 0.6 |
| Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST) - Seeking Alpha | Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST) Seeking Alpha | View source ↗ | Seeking Alpha | Jun 3, 2026 | neutral | 0 | 0.6 |
| $MIST stock is up 10% today. Here's what we see in our data. - Quiver Quantitative | $MIST stock is up 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.